Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immunochemistry Analyzer Suitable for Low- to Mid-Volume Labs

By Labmedica staff writers
Posted on 22 Apr 2008
A new immunochemistry analyzer has been introduced, which was designed for labs that typically perform less than 200 immunoassay tests per day. More...
The instrument addresses many of the workflow challenges common in today's laboratories.

Called the Architect i1000SR analyzer, the new instrument enhances workflow and boosts laboratory productivity. Developed by Abbott (Abbott Park, IL, USA), the analyzer expands the Architect family of diagnostics instrument systems for clinical laboratories. The Architect i1000SR provides continuous access to reagents and samples while the instrument is running, enhancing laboratory productivity. Additionally, a wide test menu, user-friendly software, and low maintenance make it easy to train new laboratory personnel on the instrument's operation.

The Architect i1000SR analyzer can process up to 100 tests per hour. The instrument accommodates 65 patient samples and has the capability to prioritize emergency test results and turn them around in less than 16 minutes.

"Because time and ease of use are so critical in the testing environment, Abbott worked extensively with customers very early in the development phase and designed an instrument that could help smaller labs overcome the same productivity obstacles faced by larger labs,” said Cass Grandone, divisional vice president, Systems Development, Abbott Diagnostics. "The Architect i1000SR analyzer is ideal for facilities running less than 200 tests per day and offers productivity benefits, such as highly efficient sample processing, usually reserved for larger testing facilities. Since Architect utilizes common reagents, consumables, and software user interfaces, larger laboratories may be interested in using the instrument as a back-up system to the i2000SR.”

Similar to Architect ci8200 and ci16200, the analyzer is part of the Architect family, with important features including: family commonality, enhanced assay and system dynamics, and integration of immunoassay and clinical chemistry technologies without jeopardizing key performance, including turnaround time or accuracy of results.


Related Links:
Abbott

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.